Andy Law's practice focuses on corporate finance and commercial transactions. He has advised on a broad range of projects including takeover, cross-border M&A, initial public offering, pre-IPO investment, private equity investment, rights issue, open offer, bond issue, placing and other general corporate and commercial matters. He also has advised financial institutions and listed companies on regulatory and compliance matters. Prior to joining Dentons, Andy worked at two U.S. law firms in Hong Kong and Beijing.

Experience

Capital Markets

  • Advised a healthcare company on its initial public offering on the Stock Exchange of Hong Kong.
  • Advised the sponsor in the initial public offering of a construction company on the Stock Exchange of Hong Kong.
  • Advised a home furnishing products trading company's placing of HK$60 million new shares under general mandate.
  • Advised a financial services company’s open offer of HK$100 million notes and issue of unlisted warrants.
  • Advised a footwear manufacturing company’s HK$500 million rights issue.
  • Advised a property investment company’s HK$29 million rights issue.
  • Advised a packaging printing company’s proposed HK$300 million 6% bonds issue.

Mergers and Acquisitions

  • Advised the offeror in the HK$180 million mandatory cash offer to acquire all the issued shares of a Hong Kong-based trading company listed on the main board of the Hong Kong Stock Exchange.
  • Advised the offeror in the HK$230 million mandatory cash offer to acquire all the issued shares of a signal processing technologies company listed on the GEM board of the Hong Kong Stock Exchange.
  • Advised a listed investment holding company, as the offeree company, to respond to a voluntary unconditional HK$254.6 million general offer made by the offeror.
  • Advised a H share pharmaceutical company’s disclosable and connected transaction in relation to the acquisition of RMB 112 million 40% of equity interest in a PRC pharmaceutical company through an open tender process.
  • Advised a PRC Personal Care Products Company's sale of its US$100 million assets relating to the manufacturing and sale of personal care products to an Indian conglomerate.
  • Advised the controlling shareholder’s pre-IPO sale of a PRC healthcare group company’s minority interests to a North American pension fund through subscription and purchase of shares.
  • Advised an internet company’s disposal of its entire equity interest in a virtual private networks business in the PRC to a Nasdaq listed company.
  • Advised a Hong Kong private company’s issuance of US$100 million notes exchangeable into ordinary shares in an offshore company engaging in iron ore mining.